Peptide Antibiotics Market 2027 By Product Type, Route of Administration, Distribution Channel | The Insight Partners

Peptide Antibiotics Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type (Ribosomal Synthesized Peptide Antibiotics, Non-ribosomal Synthesized Peptide Antibiotics); Route of Administration (Oral, Intravenous, Intramuscular, Topical, Others); Distribution Channel (Hospital, Retail Pharmacy, Drug Stores, Others)

Report Code: TIPRE00015179 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Covid
MARKET INTRODUCTION

Peptide antibiotics relate to the class of anti-infective and antitumor antibiotic comprising polypeptide chains. These peptide antibiotics usually fall into two types ribosomal synthesized and non-ribosomal synthesized peptide antibiotics. Due to several advantages of peptide antibiotics such as high efficacy, high specificity, low toxicity, etc. the peptide antibiotics are highly demanding. Also, due to rising antibiotic resistance cases, creating a threat for the manufacturer, the peptide antibiotics were taken into account to overcome the above issue.

MARKET DYNAMICS

The peptide antibiotics market is driving due to rising demand for peptide antibiotics in hospitals and clinics, intensive research, and development activities in peptide antibiotics. However, side effects are related to the long-term use of peptide antibiotics, hampering the peptide antibiotics market's growth. Moreover, recent advancement and innovation in peptide antibiotics are expected to provide opportunities in the global peptide antibiotics market.

MARKET SCOPE

The "Peptide Antibiotics Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of peptide antibiotics market with detailed market segmentation by product type, route of administration, and distribution channel. The peptide antibiotics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in peptide antibiotics market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The peptide antibiotics market is segmented on the basis of product type, route of administration, and distribution channel. Based on product type, the market is segmented as ribosomal synthesized peptide antibiotics and non-ribosomal synthesized peptide antibiotics. Based on route of administration, the market is segmented as oral, intravenous, intramuscular, topical, and others. Based on distribution channel, the market is segmented as hospital, retail pharmacy, drug stores, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the peptide antibiotics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The peptide antibiotics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting peptide antibiotics market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the peptide antibiotics market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the peptide antibiotics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Peptide antibiotics market are anticipated to have lucrative growth opportunities in the future with the rising demand for peptide antibiotics in the global market. Below mentioned is the list of few companies engaged in the peptide antibiotics market.

The report also includes the profiles of key players in peptide antibiotics market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Eli Lilly and Company
  •   GlaxoSmithKline plc
  •   Madam Therapeutics
  •   Novartis AG
  •   Pfizer, Inc.
  •   Theravance Biopharma
  •   Pacgen Life Science Corporation
  •   Phosphagenics Limited
  •   Kasten
  •   Savara Pharmaceuticals

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Peptide Antibiotics Market - By Product Type
1.3.2 Peptide Antibiotics Market - By Route of Administration
1.3.3 Peptide Antibiotics Market - By Distribution Channel
1.3.4 Peptide Antibiotics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PEPTIDE ANTIBIOTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PEPTIDE ANTIBIOTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PEPTIDE ANTIBIOTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. PEPTIDE ANTIBIOTICS - GLOBAL MARKET OVERVIEW
6.2. PEPTIDE ANTIBIOTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PEPTIDE ANTIBIOTICS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. RIBOSOMAL SYNTHESIZED PEPTIDE ANTIBIOTICS
7.3.1. Overview
7.3.2. Ribosomal Synthesized Peptide Antibiotics Market Forecast and Analysis
7.4. NON-RIBOSOMAL SYNTHESIZED PEPTIDE ANTIBIOTICS
7.4.1. Overview
7.4.2. Non-ribosomal Synthesized Peptide Antibiotics Market Forecast and Analysis
8. PEPTIDE ANTIBIOTICS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INTRAVENOUS
8.4.1. Overview
8.4.2. Intravenous Market Forecast and Analysis
8.5. INTRAMUSCULAR
8.5.1. Overview
8.5.2. Intramuscular Market Forecast and Analysis
8.6. TOPICAL
8.6.1. Overview
8.6.2. Topical Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. PEPTIDE ANTIBIOTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL
9.3.1. Overview
9.3.2. Hospital Market Forecast and Analysis
9.4. RETAIL PHARMACY
9.4.1. Overview
9.4.2. Retail Pharmacy Market Forecast and Analysis
9.5. DRUG STORES
9.5.1. Overview
9.5.2. Drug Stores Market Forecast and Analysis
9.6. OTHERS
9.6.1. Overview
9.6.2. Others Market Forecast and Analysis
10. PEPTIDE ANTIBIOTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Peptide Antibiotics Market Overview
10.1.2 North America Peptide Antibiotics Market Forecasts and Analysis
10.1.3 North America Peptide Antibiotics Market Forecasts and Analysis - By Product Type
10.1.4 North America Peptide Antibiotics Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Peptide Antibiotics Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Peptide Antibiotics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Peptide Antibiotics Market
10.1.6.1.1 United States Peptide Antibiotics Market by Product Type
10.1.6.1.2 United States Peptide Antibiotics Market by Route of Administration
10.1.6.1.3 United States Peptide Antibiotics Market by Distribution Channel
10.1.6.2 Canada Peptide Antibiotics Market
10.1.6.2.1 Canada Peptide Antibiotics Market by Product Type
10.1.6.2.2 Canada Peptide Antibiotics Market by Route of Administration
10.1.6.2.3 Canada Peptide Antibiotics Market by Distribution Channel
10.1.6.3 Mexico Peptide Antibiotics Market
10.1.6.3.1 Mexico Peptide Antibiotics Market by Product Type
10.1.6.3.2 Mexico Peptide Antibiotics Market by Route of Administration
10.1.6.3.3 Mexico Peptide Antibiotics Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Peptide Antibiotics Market Overview
10.2.2 Europe Peptide Antibiotics Market Forecasts and Analysis
10.2.3 Europe Peptide Antibiotics Market Forecasts and Analysis - By Product Type
10.2.4 Europe Peptide Antibiotics Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Peptide Antibiotics Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Peptide Antibiotics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Peptide Antibiotics Market
10.2.6.1.1 Germany Peptide Antibiotics Market by Product Type
10.2.6.1.2 Germany Peptide Antibiotics Market by Route of Administration
10.2.6.1.3 Germany Peptide Antibiotics Market by Distribution Channel
10.2.6.2 France Peptide Antibiotics Market
10.2.6.2.1 France Peptide Antibiotics Market by Product Type
10.2.6.2.2 France Peptide Antibiotics Market by Route of Administration
10.2.6.2.3 France Peptide Antibiotics Market by Distribution Channel
10.2.6.3 Italy Peptide Antibiotics Market
10.2.6.3.1 Italy Peptide Antibiotics Market by Product Type
10.2.6.3.2 Italy Peptide Antibiotics Market by Route of Administration
10.2.6.3.3 Italy Peptide Antibiotics Market by Distribution Channel
10.2.6.4 Spain Peptide Antibiotics Market
10.2.6.4.1 Spain Peptide Antibiotics Market by Product Type
10.2.6.4.2 Spain Peptide Antibiotics Market by Route of Administration
10.2.6.4.3 Spain Peptide Antibiotics Market by Distribution Channel
10.2.6.5 United Kingdom Peptide Antibiotics Market
10.2.6.5.1 United Kingdom Peptide Antibiotics Market by Product Type
10.2.6.5.2 United Kingdom Peptide Antibiotics Market by Route of Administration
10.2.6.5.3 United Kingdom Peptide Antibiotics Market by Distribution Channel
10.2.6.6 Rest of Europe Peptide Antibiotics Market
10.2.6.6.1 Rest of Europe Peptide Antibiotics Market by Product Type
10.2.6.6.2 Rest of Europe Peptide Antibiotics Market by Route of Administration
10.2.6.6.3 Rest of Europe Peptide Antibiotics Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Peptide Antibiotics Market Overview
10.3.2 Asia-Pacific Peptide Antibiotics Market Forecasts and Analysis
10.3.3 Asia-Pacific Peptide Antibiotics Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Peptide Antibiotics Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Peptide Antibiotics Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Peptide Antibiotics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Peptide Antibiotics Market
10.3.6.1.1 Australia Peptide Antibiotics Market by Product Type
10.3.6.1.2 Australia Peptide Antibiotics Market by Route of Administration
10.3.6.1.3 Australia Peptide Antibiotics Market by Distribution Channel
10.3.6.2 China Peptide Antibiotics Market
10.3.6.2.1 China Peptide Antibiotics Market by Product Type
10.3.6.2.2 China Peptide Antibiotics Market by Route of Administration
10.3.6.2.3 China Peptide Antibiotics Market by Distribution Channel
10.3.6.3 India Peptide Antibiotics Market
10.3.6.3.1 India Peptide Antibiotics Market by Product Type
10.3.6.3.2 India Peptide Antibiotics Market by Route of Administration
10.3.6.3.3 India Peptide Antibiotics Market by Distribution Channel
10.3.6.4 Japan Peptide Antibiotics Market
10.3.6.4.1 Japan Peptide Antibiotics Market by Product Type
10.3.6.4.2 Japan Peptide Antibiotics Market by Route of Administration
10.3.6.4.3 Japan Peptide Antibiotics Market by Distribution Channel
10.3.6.5 South Korea Peptide Antibiotics Market
10.3.6.5.1 South Korea Peptide Antibiotics Market by Product Type
10.3.6.5.2 South Korea Peptide Antibiotics Market by Route of Administration
10.3.6.5.3 South Korea Peptide Antibiotics Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Peptide Antibiotics Market
10.3.6.6.1 Rest of Asia-Pacific Peptide Antibiotics Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Peptide Antibiotics Market by Route of Administration
10.3.6.6.3 Rest of Asia-Pacific Peptide Antibiotics Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Peptide Antibiotics Market Overview
10.4.2 Middle East and Africa Peptide Antibiotics Market Forecasts and Analysis
10.4.3 Middle East and Africa Peptide Antibiotics Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Peptide Antibiotics Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Peptide Antibiotics Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Peptide Antibiotics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Peptide Antibiotics Market
10.4.6.1.1 South Africa Peptide Antibiotics Market by Product Type
10.4.6.1.2 South Africa Peptide Antibiotics Market by Route of Administration
10.4.6.1.3 South Africa Peptide Antibiotics Market by Distribution Channel
10.4.6.2 Saudi Arabia Peptide Antibiotics Market
10.4.6.2.1 Saudi Arabia Peptide Antibiotics Market by Product Type
10.4.6.2.2 Saudi Arabia Peptide Antibiotics Market by Route of Administration
10.4.6.2.3 Saudi Arabia Peptide Antibiotics Market by Distribution Channel
10.4.6.3 U.A.E Peptide Antibiotics Market
10.4.6.3.1 U.A.E Peptide Antibiotics Market by Product Type
10.4.6.3.2 U.A.E Peptide Antibiotics Market by Route of Administration
10.4.6.3.3 U.A.E Peptide Antibiotics Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Peptide Antibiotics Market
10.4.6.4.1 Rest of Middle East and Africa Peptide Antibiotics Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Peptide Antibiotics Market by Route of Administration
10.4.6.4.3 Rest of Middle East and Africa Peptide Antibiotics Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Peptide Antibiotics Market Overview
10.5.2 South and Central America Peptide Antibiotics Market Forecasts and Analysis
10.5.3 South and Central America Peptide Antibiotics Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Peptide Antibiotics Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Peptide Antibiotics Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Peptide Antibiotics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Peptide Antibiotics Market
10.5.6.1.1 Brazil Peptide Antibiotics Market by Product Type
10.5.6.1.2 Brazil Peptide Antibiotics Market by Route of Administration
10.5.6.1.3 Brazil Peptide Antibiotics Market by Distribution Channel
10.5.6.2 Argentina Peptide Antibiotics Market
10.5.6.2.1 Argentina Peptide Antibiotics Market by Product Type
10.5.6.2.2 Argentina Peptide Antibiotics Market by Route of Administration
10.5.6.2.3 Argentina Peptide Antibiotics Market by Distribution Channel
10.5.6.3 Rest of South and Central America Peptide Antibiotics Market
10.5.6.3.1 Rest of South and Central America Peptide Antibiotics Market by Product Type
10.5.6.3.2 Rest of South and Central America Peptide Antibiotics Market by Route of Administration
10.5.6.3.3 Rest of South and Central America Peptide Antibiotics Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PEPTIDE ANTIBIOTICS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PEPTIDE ANTIBIOTICS MARKET, KEY COMPANY PROFILES
13.1. ELI LILLY AND COMPANY
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. GLAXOSMITHKLINE PLC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. MADAM THERAPEUTICS
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. NOVARTIS AG
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. PFIZER, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. THERAVANCE BIOPHARMA
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. PACGEN LIFE SCIENCE CORPORATION
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. PHOSPHAGENICS LIMITED
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. KASTEN
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SAVARA PHARMACEUTICALS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Eli Lilly and Company
2. GlaxoSmithKline plc
3. Madam Therapeutics
4. Novartis AG
5. Pfizer, Inc.
6. Theravance Biopharma
7. Pacgen Life Science Corporation
8. Phosphagenics Limited
9. Kasten
10. Savara Pharmaceuticals
TIPRE00015179
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking